IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Temporomandibular Disorders
University of Maryland, Baltimoremonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Temporomandibular Disorders cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Granisetron Karolinska Institutet | Phase 4 | BB |
Trazodone Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 | BB |
NORAMITRIPTYLINE Duke University | Phase 2 | B |
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE University of Maryland, Baltimore | Phase 1/2 | CCC |
ETHYLICUM University of Florida | N/A | D |
DICLOFENAC Istanbul University | N/A | D |
Capsaicin Istanbul University | N/A | D |
Same molecule, other indications
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →